Why Complete Dose Access Matters for Long-Term Success
Complete Wegovy or Mounjaro for Weight Loss Dose Journey at One Pharmacy
When comparing Wegovy or Mounjaro for weight loss, one critical factor often gets overlooked: dose continuity. Both treatments require mandatory 16-week escalation schedules, progressing through five distinct doses before reaching maintenance. Wegovy follows the path of 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro follows an identical escalation pattern, though with its dual GIP and GLP-1 mechanism of action.
EverydayMeds stocks every dose of both treatments, meaning your choice between Wegovy or Mounjaro for weight loss isn't limited by pharmacy availability. Many patients discover mid-treatment that their pharmacy lacks higher doses, forcing disruptive switches during critical escalation phases. Our comprehensive inventory ensures seamless progression whether you're prescribed Wegovy's GLP-1-only approach or Mounjaro's innovative dual-hormone targeting system.
Wegovy vs Mounjaro Pricing: Complete Cost Transparency
Understanding the full financial commitment when choosing between Wegovy or Mounjaro for weight loss requires seeing all doses upfront. Wegovy pricing at EverydayMeds starts at £79.99 for 0.25mg starter pens, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for 2.4mg maintenance doses. New customers apply code FIRST40 at checkout to reach these prices, while returning customers use DOSE25.
Our Step-Up bundles provide convenient multi-dose packages for extended treatment phases. The Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks of either Wegovy or Mounjaro for weight loss treatment. The Progress Trio (0.5mg, 1mg, 1.7mg) at £369.99 suits patients requiring slower escalation or extended time at intermediate doses. For maintenance phase planning, our Ultimate Stability Trio provides three months of 2.4mg supply at £649.99.
Clinical Evidence: What Studies Show About Wegovy or Mounjaro for Weight Loss
Clinical trials demonstrate both options' effectiveness when prescribed alongside reduced-calorie diet and increased physical activity. The STEP programme evaluated Wegovy across multiple populations, with STEP 1 showing average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained results of approximately clinically studied weight loss at two years.
Mounjaro's SURMOUNT trials revealed its dual GIP and GLP-1 agonist mechanism may offer distinct benefits for some patients. However, direct comparison between Wegovy or Mounjaro for weight loss outcomes requires careful consideration of different trial designs and patient populations. Your prescriber can evaluate which mechanism—single or dual hormone targeting—best suits your individual circumstances.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones released after eating. This prescription-only medicine works primarily in two ways: it slows gastric emptying, helping you feel full longer after meals, and acts on appetite centres in the brain to reduce food cravings and overall caloric intake. The once-weekly injection is administered using Novo Nordisk's FlexTouch pen system, designed for easy self-administration. Clinical studies suggest Wegovy may also influence food preference, with some patients reporting reduced cravings for high-calorie foods. The 2.4mg maintenance dose represents the optimal balance between efficacy and tolerability established through extensive clinical trials. This mechanism makes Wegovy particularly effective when combined with lifestyle modifications including structured meal planning and regular physical activity.
Streamlined Ordering Process: From Assessment to Delivery
Accessing either Wegovy or Mounjaro for weight loss through EverydayMeds begins with our 3-minute online clinical assessment, designed to capture essential medical history and current health status. Our team of qualified prescribers reviews each application within 3 working days (express 24-hour review available), ensuring appropriate prescribing aligned with MHRA licensing and NICE TA875 guidelines. Once approved, your chosen treatment ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. All deliveries require signature confirmation and include comprehensive patient information leaflets plus injection technique guidance. Our GPhC-registered pharmacy (#9012878) maintains full traceability throughout the supply chain, from manufacturer to your door. Follow-up assessments ensure ongoing clinical appropriateness and dose optimization throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements present one practical difference when choosing between Wegovy or Mounjaro for weight loss. Wegovy pens maintain stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage at 2-8°C before first use and should never be frozen or shaken. The FlexTouch delivery system used by Wegovy features a dose counter window and audio-tactile feedback confirming successful injection. Pre-filled pens contain exactly four doses each, requiring weekly replacement throughout treatment. Injection sites should rotate between thigh, upper arm, or abdomen areas to prevent lipodystrophy. Both treatments require disposal in appropriate sharps containers available free from most pharmacies.
Dose Escalation Strategy: Why Every Dose Matters for Wegovy or Mounjaro Success
The mandatory 16-week escalation schedule isn't arbitrary—it's clinically designed to minimize gastrointestinal side effects while maximizing treatment adherence. Starting both Wegovy or Mounjaro for weight loss at maintenance doses would likely cause intolerable nausea, vomiting, and treatment discontinuation. Each dose level allows your digestive system to adapt gradually while building therapeutic efficacy. Some patients require extended time at intermediate doses due to side effects or slower tolerance development.
EverydayMeds' complete dose inventory accommodates these individual variations without treatment interruption. Our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) provides eight weeks at starter dose for patients requiring slower progression. Consistency bundles offer duplicate doses for extended stabilization periods. This flexibility proves crucial because rushing dose escalation often leads to treatment failure, while having every dose readily available supports successful long-term weight management outcomes.
Making Your Choice: Expert Support for Wegovy or Mounjaro Decisions
Both Wegovy and Mounjaro represent evidence-based approaches to medical weight management, each available with complete dose ranges at EverydayMeds. Your prescriber will consider factors including your medical history, current medications, previous weight loss attempts, and individual risk factors when recommending between these options. Our clinical team provides ongoing support throughout your treatment journey, ensuring optimal outcomes whether you're prescribed Wegovy's established GLP-1 approach or Mounjaro's innovative dual-mechanism therapy. With discount codes FIRST40 for new customers and DOSE25 for returning patients applied at checkout, plus nationwide next-day delivery from our GPhC-registered pharmacy (#9012878), we're committed to supporting your long-term success. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and access the complete range of doses for your chosen prescription-only weight management treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
